Comparison of Oral Brivaracetam Versus Levetiracetam as Monotherapy in Epilepsy

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Epilepsy
Interventions
DRUG

Brivaracetam

Brivaracetam was initiated at a dose of 1-2 mg/kg/day in two divided doses, titrated to a maximum of 5 mg/kg/day based on clinical response and tolerability.

DRUG

Levetiracetam

Levetiracetam was initiated at a dose of 10-20 mg/kg/day in two divided doses, with gradual escalation up to 60 mg/kg/day if needed.

Trial Locations (1)

66000

The Children's Hospital and Institute of Child Health, Multan

All Listed Sponsors
lead

RESnTEC, Institute of Research

OTHER

NCT07163585 - Comparison of Oral Brivaracetam Versus Levetiracetam as Monotherapy in Epilepsy | Biotech Hunter | Biotech Hunter